| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |